<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mpath ids='MPATH_3'>Apoptosis</z:mpath> of hematopoietic progenitor cells is increased in <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>We have studied Fas (CD95/Apo-1) antigen expression in 27 MDS patients (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RARS</z:e> 4, RA 3, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> 13; <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t 3, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> 4) and three <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> secondary to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We found that the Fas antigen was not expressed on <z:mpath ids='MPATH_458'>normal</z:mpath> bone marrow (BM) CD34+, CD14+, or glycophorin+ cells, and only slightly on CD33+ cells </plain></SENT>
<SENT sid="3" pm="."><plain>Patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> had upregulation of Fas expression on total bone marrow nuclear cells (BMMC) (t-test, P = 0.04), CD34+ (P = 0.013), CD33+ (P = 0.04), and glycophorin+ (P = 0.032) BM cells compared to controls </plain></SENT>
<SENT sid="4" pm="."><plain>Fas expression did not correlate to the FAB subtype, the Bournemouth score, or to peripheral cytopenias </plain></SENT>
<SENT sid="5" pm="."><plain>However, Fas expression intensity on CD34+ cells negatively correlated to the BM blasts number (Spearman, P = 0.01) suggesting that leukemic blasts cells lose Fas antigen expression with progression of <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Using both proliferation assays in liquid cultures and clonogenic progenitor assays in the presence of an <z:chebi fb="4" ids="48705">agonist</z:chebi> anti-Fas MoAb (CH11), we showed that the Fas protein was functional in some patients </plain></SENT>
<SENT sid="7" pm="."><plain>Dose-dependent inhibition of DNA synthesis was observed in three out of seven patients studied </plain></SENT>
<SENT sid="8" pm="."><plain>CFU-GM and BFU-E colonies suppression in some patients suggested that Fas can induce <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in myeloid and erythroid BM progenitors of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients </plain></SENT>
<SENT sid="9" pm="."><plain>The TUNEL technique on BM smears gave a mean of 12.6% +/- 2.5 of bone marrow apoptotic cells in five controls </plain></SENT>
<SENT sid="10" pm="."><plain>Patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> had increased bone marrow <z:mpath ids='MPATH_3'>apoptosis</z:mpath> (mean 39% +/- 5.7, t-test, P = 0.012) </plain></SENT>
<SENT sid="11" pm="."><plain>Four out of 15 (26%) patients studied with a sensitive radiolabeled DNA ladder technique had typical DNA ladders indicative of advanced stages of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="12" pm="."><plain>Massive BM <z:e sem="disease" ids="C0812393,C0038661" disease_type="Mental or Behavioral Dysfunction;Injury or Poisoning" abbrv="">suicide</z:e> was observed in patients with RA (2/2) and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> (8/11), whereas <z:mpath ids='MPATH_3'>apoptosis</z:mpath> rates were <z:mpath ids='MPATH_458'>normal</z:mpath> or low in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t (3/3) or <z:e sem="disease" ids="C0280449" disease_type="Neoplastic Process" abbrv="">secondary AMLs</z:e> (3/3) </plain></SENT>
<SENT sid="13" pm="."><plain>Moreover, high rates of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> correlated to low Bournemouth score (Spearman, P = 0.01) </plain></SENT>
<SENT sid="14" pm="."><plain>No statistical correlation could be found between Fas expression and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> rates </plain></SENT>
<SENT sid="15" pm="."><plain>Our results confirm the importance of programmed cell <z:hpo ids='HP_0011420'>death</z:hpo> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="16" pm="."><plain>The Fas antigen is clearly upregulated on BM cells, but its role in the pathophysiology of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> is still unclear, indicating that many factors positively or negatively interfere with the Fas-mediated pathway of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in vivo and in vitro </plain></SENT>
</text></document>